PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Clinical trials for PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in battle against tough ovarian cancer
Disease control CompletedThis study tested two different ways of giving immunotherapy drugs (durvalumab and tremelimumab) to women with recurrent ovarian, fallopian tube, or primary peritoneal cancer that had stopped responding to standard platinum-based chemotherapy. The goal was to see if giving the dr…
Matched conditions: PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat ovarian cancer
Disease control CompletedThis study tested a new drug called SL-172154, given alongside one of two standard chemotherapy drugs, in people with ovarian cancer that had stopped responding to platinum-based treatments. The main goals were to find a safe dose and see if the combinations showed early signs of…
Matched conditions: PLATINUM-RESISTANT PRIMARY PERITONEAL CARCINOMA
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC